Sep 02, 2026
In recent years, “focal therapy”—which includes High-Intensity Focused Ultrasound (HIFU), cryotherapy, photodynamic therapy, and irreversible electroporation (NanoKnife)—has been widely marketed as a…
Read More →
Sep 02, 2026
For men undergoing radical prostatectomy, achieving a complete cancer cure is the primary objective. However, long-term quality of life—specifically the preservation and…
Read More →
Aug 31, 2026
In intermediate- and high-risk prostate cancer, removing the primary tumor inside the prostate gland represents only half of the oncological objective. Because…
Read More →
Aug 26, 2026
Among the primary concerns facing men diagnosed with localized prostate cancer, the fear of chronic urinary incontinence is paramount. The thought of…
Read More →
Aug 10, 2026
A prostate cancer diagnosis in a man in his late 60s, 70s, or early 80s was historically met with a standardized clinical…
Read More →
Aug 07, 2026
Discovering that your prostate cancer has returned or persisted after undergoing initial radiation therapy, proton beam treatment, brachytherapy (seeds), or focal therapies…
Read More →
Aug 05, 2026
A rising Prostate-Specific Antigen (PSA) level following primary treatment—known clinically as biochemical recurrence—is a deeply anxious moment for any patient. Historically, when…
Read More →
Aug 04, 2026
Receiving a prostate cancer diagnosis is daunting, but learning that your pathology report shows a High-Gleason score (Gleason 8, 9, or 10)…
Read More →
Jul 31, 2026
For corporate executives, business leaders, and active professionals across Long Island, managing health often becomes an afterthought amidst demanding schedules and travel…
Read More →
212-365-5000